SCIENTIFIC BACKGROUND

AZF

About 0.6-1% of all infertile men have microdeletions in the azoospermia factor (AZF) region of the Y chromosome. The prevalence of AZF deletions is 15-20% in non-obstructive azoospermia and about 7-10% in severe oligozoospermia. The DAZ and RBM genes, which are essential for spermatogenesis, are located in the AZF region. Deletions in this area lead to testicular maturation arrest of the spermatogenesis or are associated with the formation of immature, aggregated sperm.

 

By amplification of a total of six Y chromosome markers from the AZFa, AZFb and AZFc regions, about 90% of the known deletions can be detected. Deletions of the AZFa or AZFb region inevitably lead to azoospermia, so that testicular sperm extraction (TESE) does not seem to be effective for fertility treatment. In contrast, AZFc deletions lead to a very heterogeneous clinical picture, ranging from severe oligozoospermia to azoospermia. In about 50% of men with AZFc deletions, sperm can be found in the testicular biopsy with TESE. Deletions in the AZFc region are passed on to male offspring after artificial insemination by ICSI (intracytoplasmic sperm injection).

 

Other known causes of azoospermia are pathogenic variants in the AR, NR5A1, DMRT1 and TEX11 genes. In patients without AZF deletions, these genes can be examined within the framework of a multi-gene analysis using NGS.

 

References

Colaco and Modi 2018, Reprod Biol Endocrinol 16:14 / Schwarzer et al. 2016, Andrologia 48:402 / Krausz et al. 2014, EAA/EMQN best practice guidelines, Andrology 2:5 / Navarro-Costa et al. 2010, J Biomed Biotechnol 2010:936569 / Tüttelmann et al. 2008, Urologe 47:1561 / Simoni et al. 2004, Int J Androl 27:240

GENES

AZF
How to order

LATEST ARTICLES

Traditional DNA tests may overlook 10% of classic in Familial Adenomatous Polyposis (FAP) cases. By integrating RNA sequencing, researchers unveiled ...

Read more

Overview In January 2024, the American Society of Clinical Oncology (ASCO) and the Society of Surgical Oncology (SSO) published new recommendation...

Read more

Endometriosis is a chronic gynecological condition that affects 1 in 10 women of reproductive age worldwide [1]. It can manifest with the first menst...

Read more

Rare Disease Day is a global awareness day held annually to raise awareness of all rare diseases. It was first celebrated in 2008, on the rarest day ...

Read more

Cancer is a group of genetic diseases that can develop almost anywhere in the body. Many people in the world are affected by cancer every year. Follo...

Read more

Aiming to evaluate the role of chromosomal aneuploidy in pregnancy loss, a 2023 study 35 years in the making evaluated the genomic landscape of first...

Read more

Cancer is a complex genetic disease that affects millions of people in the world. It is one of the leading causes of death worldwide, with about ten ...

Read more

Researchers created a detailed map of the placenta during labor. By studying how maternal and fetal cells communicate, they discovered signals in the...

Read more

A recent paper published in Nature Medicine (1) aimed to identify genes and genomic biomarkers which can better predict outcomes and personalized the...

Read more

In honor of the international day of women and girls in science, we interviewed one of our very own, Dr. Evelina Papaioannou. Dr. Evelina Pa...

Read more